- Home
- PHVS vs UWMC Comparison
PHVS vs UWMC Comparison
Compare PHVS & UWMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHVS
- UWMC
- Stock Information
- Founded
- PHVS 2015
- UWMC 1986
- Country
- PHVS Switzerland
- UWMC United States
- Employees
- PHVS N/A
- UWMC N/A
- Industry
- PHVS Biotechnology: Pharmaceutical Preparations
- UWMC Finance: Consumer Services
- Sector
- PHVS Health Care
- UWMC Finance
- Exchange
- PHVS Nasdaq
- UWMC Nasdaq
- Market Cap
- PHVS 980.9M
- UWMC 876.2M
- IPO Year
- PHVS 2021
- UWMC N/A
- Fundamental
- Price
- PHVS $20.06
- UWMC $4.66
- Analyst Decision
- PHVS Buy
- UWMC Hold
- Analyst Count
- PHVS 6
- UWMC 7
- Target Price
- PHVS $37.17
- UWMC $5.54
- AVG Volume (30 Days)
- PHVS 216.0K
- UWMC 7.5M
- Earning Date
- PHVS 08-13-2025
- UWMC 08-07-2025
- Dividend Yield
- PHVS N/A
- UWMC 8.89%
- EPS Growth
- PHVS N/A
- UWMC 559.85
- EPS
- PHVS N/A
- UWMC 0.21
- Revenue
- PHVS N/A
- UWMC $2,807,779,000.00
- Revenue This Year
- PHVS N/A
- UWMC $16.65
- Revenue Next Year
- PHVS N/A
- UWMC $16.18
- P/E Ratio
- PHVS N/A
- UWMC $21.90
- Revenue Growth
- PHVS N/A
- UWMC 20.04
- 52 Week Low
- PHVS $11.51
- UWMC $3.80
- 52 Week High
- PHVS $26.33
- UWMC $9.74
- Technical
- Relative Strength Index (RSI)
- PHVS 48.84
- UWMC 57.23
- Support Level
- PHVS $20.06
- UWMC $4.20
- Resistance Level
- PHVS $22.30
- UWMC $4.91
- Average True Range (ATR)
- PHVS 1.13
- UWMC 0.20
- MACD
- PHVS -0.23
- UWMC 0.02
- Stochastic Oscillator
- PHVS 22.84
- UWMC 53.51
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About UWMC UWM Holdings Corporation
UWM Holdings Corp engages in the origination, sale, and servicing of residential mortgage loans in the wholesale channel. The company provides independent mortgage advisors across the states and the district of Columbia.